Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors

ConclusionsThese findings suggest the clinical significance of pretreatment sPD-L1 as well as posttreatment sPD-1 and sPD-L1 in NSCLC patients treated with ICI monotherapy.

Source: Cancer Immunology, Immunotherapy - May 16, 2023 Category: Cancer & Oncology Source Type: research